Drug Trial Radar · NCT04238676
Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain
Last checked: Nov 19, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
43
Actual
Start
Jan 20, 2020
Primary completion
Dec 9, 2024
Study completion Dec 9, 2024
Sponsor
- Lead sponsor
- Persica Pharmaceuticals LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Micron Research Ltd
- First posted
- Jan 23, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1b study to investigate the efficacy of PP353 compared to placebo in the treatment of chronic low back pain associated with bone oedema.
Conditions
- Chronic Low-back Pain
Interventions
PP353Drug
active administered by intradiscal injection
PlaceboOther
Sham injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse EventsTime frame: 0 to 12 months
- Change From Baseline in Low Back Pain Numerical Rating Scale (LBP NRS) ScoreTime frame: 12 months
Locations
10 sites in 4 countries. Site status is shown where the registry gives one.
Gildhøj Privathospital København
Copenhagen, Denmark
CGM Research Trust
Christchurch, New Zealand
Hospital Vithas Granada
Granada, Spain
Hospital Universitario LA PAZ
Madrid, Spain
University Hospital Coventry & Warwickshire
Coventry, United Kingdom
Leeds General Infirmary
Leeds, United Kingdom
University Hospital Southampton Nhs Foundation Trust
Southampton, United Kingdom
Royal Preston Hospital
Preston, Lancashire, United Kingdom
Oxford University Hospitals NHS Foundation Trust
Oxford, Oxford, United Kingdom
University Hospital Of Wales
Cardiff, Wales, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.